Osteoporosis and Osteopenia
Estimated time to complete session: 45 mins.
Upon completion of this session, you should be able to:
1. Evaluate elderly patients or patients at risk for low bone mass/osteoporosis using the FRAX algorithm, and consider the impact of fracture risk scores on patient management.
2. Advise patients on appropriate prophylactic strategies for patients with low bone mass/osteoporosis.
3. Compare and contrast management with RANKL inhibitor vs bisphosphonates, and the pros and cons between various bisphosphonates.
4. Determine the risks and benefits of maintaining bisphosphonate treatment for greater than 5 years.
View technical requirements (opens in a new window).
View CME credit information (opens in a new window).
View disclosures and disclaimers (opens in a new window).
All materials herein are protected by copyright and are for the sole, personal use of the purchaser. No part of the written, oral, and broadcast production may be copied, duplicated, replicated or retransmitted without the prior permission of the applicable copyright owner.
The unauthorized reproduction or distribution of a copyrighted work is illegal. Criminal copyright infringement, including infringement without monetary gain, is investigated by the FBI and is punishable by up to five years in federal prison and a fine of $250,000.
David T. Walsworth, MD, FAAFP – Course Chair; Associate Chair for Clinical Affairs; Associate Professor, Department of Family Medicine, College of Human Medicine, Michigan State University, East Lansing
- 0.75 AAFP prescribed